Table of Contents
Cephalexin is a widely used antibiotic in the treatment of skin and soft tissue infections. It belongs to the class of antibiotics known as cephalosporins, which are similar to penicillins but often more effective against certain bacteria.
Understanding Skin and Soft Tissue Infections
Skin and soft tissue infections (SSTIs) include a variety of conditions such as cellulitis, impetigo, abscesses, and wound infections. These infections are commonly caused by bacteria like Staphylococcus aureus and Streptococcus pyogenes.
Mechanism of Action of Cephalexin
Cephalexin works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacteria. It is bactericidal and effective against a broad range of Gram-positive bacteria, making it suitable for SSTIs caused by these pathogens.
Indications for Use
- Cellulitis
- Impetigo
- Wound infections
- Abscesses (as part of combined therapy)
Dosage and Administration
The typical adult dose of cephalexin for SSTIs is 500 mg to 1000 mg every 6 to 12 hours, depending on the severity of the infection. It is usually prescribed for 7 to 14 days. Patients should complete the full course to prevent resistance.
Advantages of Cephalexin
- Effective against common SSTI pathogens
- Good oral bioavailability
- Generally well-tolerated with minimal side effects
- Convenient dosing schedule
Limitations and Considerations
Cephalexin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA). It should be used cautiously in patients with allergies to penicillins or cephalosporins. Resistance can develop if not used appropriately.
Conclusion
Cephalexin remains a valuable antibiotic for treating many skin and soft tissue infections, especially those caused by susceptible Gram-positive bacteria. Proper use and adherence to prescribed regimens are essential for effective treatment and minimizing resistance.